<p class=ldtitle>A BILL to amend and reenact ยงยง 38.2-3407.22, 38.2-3465, 38.2-3466, and 38.2-3467 of the Code of Virginia and to amend the Code of Virginia by adding sections numbered 38.2-3467.1 and 38.2-3467.2, relating to health insurance; ensuring fairness in cost-sharing; pharmacy benefits managers; compensation and duties; civil penalty.</p>
Impact
If enacted, the bill will significantly impact the operations of PBMs and their interactions with pharmacies and state employees. By mandating specific reimbursement rates and standards, SB413 aims to reduce the financial burdens on pharmacies and ensure that state employees have reasonable access to medications. The bill also includes provisions for civil penalties against PBMs that fail to comply with its regulations, reinforcing accountability within the pharmacy benefits management sector.
Summary
Senate Bill 413 focuses on amending certain provisions related to health insurance and pharmacy benefits management in the state of Virginia. The bill introduces regulations for pharmacy benefits managers (PBMs), outlining their duties and responsibilities within the management of prescription drug benefits. Notably, it establishes a requirement for PBMs to reimburse in-network pharmacies at the national average drug acquisition cost plus a professional dispensing fee, promoting a more equitable compensation structure for pharmacies servicing state employees.
Sentiment
The sentiment surrounding SB413 appears to be cautiously optimistic among proponents who argue that it promotes fairness among pharmacies and enhances prescription drug access for state employees. However, there is concern among some stakeholders about the potential increased administrative costs for PBMs and the operational challenges they might face. This has led to a mix of support and apprehension within the healthcare industry, highlighting the balance that must be struck between regulatory oversight and operational flexibility.
Contention
One of the notable points of contention regarding SB413 revolves around the balance of power in decision-making between PBMs and pharmacies. While supporters argue that the bill will protect pharmacies from unfair practices and ensure adequate reimbursement, opponents raise concerns about the operational constraints that the legislation could impose on PBMs. Additional debates have surfaced regarding the potential for increased costs to consumers if PBMs pass along their compliance costs, making it a crucial aspect of the ongoing discussion on this legislation.
Requires health care professional to order bi-lateral ultrasounds concurrently when ordering mammograms; requires insurers to cover concurrent mammograms and bi-lateral ultrasounds.
Requires health care professionals to order bi-lateral ultrasounds concurrently when ordering mammograms; requires insurers to cover concurrent mammograms and bi-lateral ultrasounds.